Use of a water-impermeable, friction-reducing barrier film (BF) may reduce skin toxicity (eg, radiation dermatitis, burning, and pruritus) on high-friction breast regions in women with breast cancer receiving post-lumpectomy adjuvant radiation therapy, according to a study.
The risk of several medical and psychiatric illnesses is higher in patients with psoriasis, but those prescribed biologic agents are less likely to develop the latter as compared to those not prescribed medications, according to a study.
Treatment with cyclosporine results in improvements, albeit statistically nonsignificant, in the Severity of Alopecia Tool score and eyelash and eyebrow assessment scales among patients with moderate-to-severe alopecia areata (AA), a recent study has shown.
Cardiovascular disease (CVD), haemoglobin ≤10 g/dL and body surface area involvement ≥10 percent on admission increase the risk of bacteraemia in Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), reports a study.
The University of Cambridge, the Royal College of Physicians, London (RCP) and the Sunway Group have launched a collaborative continuing medical education (CME) seminar series for Malaysian healthcare professionals.
Use of cycline antibiotics (CAs) is associated with an elevated risk of pseudotumour cerebri syndrome (PTCS) or papilledema, suggests a recent study. However, no statistically significant link between CA use and PTCS development is seen when accounting for confounding factors.
The first-in-class interleukin (IL)-17A monoclonal antibody secukinumab is a safe and effective treatment for moderate-to-severe plaque psoriasis, with efficacy rates similar to those found in its phase III studies and enduring up to a year from start of treatment.
Prominent members from the Malaysian Society of Allergy and Immunology (MSAI) and Dermatological Society of Malaysia (PDM) came together to establish a coalition called the Malaysian Urticaria Expert Group (MARTEG).